Stifel Financial
WINT

Stifel Financial’s Windtree Therapeutics Inc WINT Stock Holding History

Stifel Financial’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,214
Closed -$4K – 2462
2015
Q4 		$4K Sell
1,214
-143
-11% -$586 ﹤0.01% 2324
2015
Q3 		$6K Buy
1,357
+107
+9% +$708 ﹤0.01% 2239
2015
Q2 		$12K Buy
1,250
+193
+18% +$2.71K ﹤0.01% 2337
2015
Q1 		$18K Sell
1,057
-572
-35% -$11.3K ﹤0.01% 2273
2014
Q4 		$26K Buy
1,629
+393
+32% +$8.64K ﹤0.01% 2249
2014
Q3 		$32K Sell
1,236
-121
-9% -$2.92K ﹤0.01% 2169
2014
Q2 		$34K Buy
1,357
+528
+64% +$13.5K ﹤0.01% 2154
2014
Q1 		$25K Buy
+829
New +$27.9K ﹤0.01% 2058

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stifel Financial's WINT Position: Q1 2016 in Review

Stifel Financial sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 1,214 shares — an estimated $4K sold.

Stifel Financial first reported a position in WINT in Q1 2014 and held it in 8 quarters. The position peaked at $34K in Q2 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Stifel Financial reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Stifel Financial sold 1,214 Windtree Therapeutics Inc shares in Q1 2016, an estimated $4K.
  • Stifel Financial first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 8 quarters.
  • Stifel Financial's Windtree Therapeutics Inc position peaked at $34K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Stifel Financial's 13F filing for Q1 2016, filed 16 May 2016.